19:22 , Sep 19, 2017 |  BC Innovations  |  Distillery Therapeutics

Neurology

INDICATION: Parkinson's disease (PD) Non-human primate studies suggest induced pluripotent stem (iPS) cell-derived dopaminergic neurons could help treat PD. The dopaminergic neurons were generated from iPS cells derived from PD patients or healthy volunteers by...
07:00 , Sep 17, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Proprotein convertase subtilisin/kextin type 6 (PCSK6; PACE4); corin serine peptidase (CORIN)

Cardiovascular disease INDICATION: Hypertension In vitro and mouse studies suggest PCSK6 could activate the blood pressure regulator CORIN to help treat hypertension. In HEK cells, pharmacological or siRNA-mediated inhibition of PCSK6 decreased CORIN activation compared...
07:00 , Apr 19, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Cardiovascular disease Atrial natriuretic peptide (ANP); corin serine peptidase (CORIN) Patient sample and mouse studies suggest upregulating CORIN or activating ANP could help treat...
07:00 , Jul 13, 2009 |  BC Week In Review  |  Company News

TapImmune management update

TapImmune Inc. (OTCBB:TPIM), Bellevue, Wash.   Business: Cancer, Infectious   Resigned: Pat McGowan as CFO and a director   Transitioning: Denis Corin will cease to be CEO while remaining president and becoming a director  ...
08:00 , Mar 6, 2006 |  BioCentury  |  Finance

Hustle and bustle at AIM

There is a growing belief among companies that London's Alternative Investment Market has shed the credibility concerns that once plagued it and is now an acceptable stock market for the blue chip international institutions that...